DaShenLin Pharmaceutical Group Co (SHSE:603233) General and Admin. Expense: ¥310 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603233 DaShenLin Pharmaceutical Group Co Ltd SHSE:603233
94 GF Score
Price ¥18.08
GF Value ¥18.79
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is DaShenLin Pharmaceutical Group Co General and Admin. Expense?

DaShenLin Pharmaceutical Group Co SHSE:603233 +2.44% 94 General and Admin. Expense is ¥310 Mil as of Mar. 2026. GuruFocus rates SHSE:603233 with a GF Score™ of 94/100 and a GF Value™ of ¥18.79 (Fairly Valued). The stock has 4 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. DaShenLin Pharmaceutical Group Co's General and Admin. Expense for the three months ended in Mar. 2026 was ¥294 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ¥310 Mil.

DaShenLin Pharmaceutical Group Co General and Admin. Expense Related Terms

DaShenLin Pharmaceutical Group Co General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for DaShenLin Pharmaceutical Group Co's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DaShenLin Pharmaceutical Group Co General and Admin. Expense Chart

DaShenLin Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 258.33 282.83 297.13 303.37 290.57

DaShenLin Pharmaceutical Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 274.99 -135.97 749.20 -597.66 294.49
SHSE:603233
94GF Score
DaShenLin Pharmaceutical Group Co Ltd SHSE:603233
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DaShenLin Pharmaceutical Group Co General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥310 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of ¥310 Mil mean?
DaShenLin Pharmaceutical Group Co (SHSE:603233) has a General and Admin. Expense of ¥310 Mil as of Mar. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on DaShenLin Pharmaceutical Group Co and its competitors.
Is DaShenLin Pharmaceutical Group Co's General and Admin. Expense too high?
DaShenLin Pharmaceutical Group Co's current General and Admin. Expense is ¥310 Mil. Overall, DaShenLin Pharmaceutical Group Co has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DaShenLin Pharmaceutical Group Co's General and Admin. Expense compare to competitors?
DaShenLin Pharmaceutical Group Co's General and Admin. Expense of ¥310 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Healthcare Providers & Services company?
A good General and Admin. Expense depends on the Healthcare Providers & Services industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on DaShenLin Pharmaceutical Group Co and its competitors. DaShenLin Pharmaceutical Group Co's current General and Admin. Expense is ¥310 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaShenLin Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, DaShenLin Pharmaceutical Group Co (SHSE:603233) is currently considered Fairly Valued. The stock's GF Value™ is ¥18.79, compared to a current price of ¥18.08 — trading 3.8% below its estimated fair value. The current General and Admin. Expense is ¥310 Mil. DaShenLin Pharmaceutical Group Co's overall GF Score™ is 94/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For DaShenLin Pharmaceutical Group Co (SHSE:603233), the current General and Admin. Expense is ¥310 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DaShenLin Pharmaceutical Group Co (SHSE:603233) Overvalued in 2026?

Based on GuruFocus' analysis, DaShenLin Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥18.08 is trading 3.8% below its estimated GF Value™ of ¥18.79. GuruFocus considers DaShenLin Pharmaceutical Group Co to be Fairly Valued.

Key valuation signals for SHSE:603233:

  • General and Admin. Expense: ¥310 Mil
  • GF Value™: ¥18.79 vs. price of ¥18.08 (3.8% below fair value)
  • GF Score™: 94/100 with 4 warning signs

No single metric tells the full story. See the SHSE:603233 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DaShenLin Pharmaceutical Group Co Business Description

Address No. 410-1, Longxi Avenue, Liwan District, Guangdong Province, Guangzhou, CHN, 510000
DaShenLin Pharmaceutical Group Co Ltd is engaged in the pharmaceutical manufacturing, retail, and wholesale business. The company is based on the development of the pharmacy chain. It primarily offers Chinese herbal medicine such as antibiotics and biochemical drugs. The business activities are geographically carried out through China.
94GF Score

Get the complete analysis for SHSE:603233

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥18.08
Price
¥18.79
GF Value